Stefania Bulotta
Overview
Explore the profile of Stefania Bulotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1020
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giuliano E, Gagliardi A, Farhan A, Voci S, Costa N, Bulotta S, et al.
ACS Appl Bio Mater
. 2025 Feb;
PMID: 39943722
Rutin is a flavonoid glycoside found in many plants, known for its various pharmacological properties. However, its therapeutic potential is limited by its low water solubility, which restricts its bioavailability....
2.
Maggisano V, Gargano A, Maiuolo J, Ortuso F, De Amicis F, Alcaro S, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39941053
Targeting the tumor microenvironment (TME) is an attractive strategy for developing new drugs with anticancer activity against triple-negative breast cancer (TNBC). Interleukins (ILs) are key players in the TME cytokine...
3.
Gagliardi A, Giuliano E, Voci S, Costa N, Bulotta S, Salvatici M, et al.
Int J Biol Macromol
. 2024 May;
269(Pt 1):132071.
PMID: 38705334
Wound healing is a challenging clinical problem and efficient wound management is essential to prevent infection. This is best done by utilizing biocompatible materials in order to complete the healing...
4.
Maggisano V, Capriglione F, Mio C, Bulotta S, Damante G, Russo D, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338696
Tumor cells release exosomes, extracellular vesicle containing various bioactive molecules such as protein, DNA and RNA. The analysis of RNA molecules packaged in exosomes may provide new potential diagnostic or...
5.
Battaglia A, Sacco A, Vecchio E, Scicchitano S, Petriaggi L, Giorgio E, et al.
Front Cell Dev Biol
. 2023 Nov;
11:1272667.
PMID: 38033861
Detachment from the extracellular matrix (ECM) is the first step of the metastatic cascade. It is a regulated process involving interaction between tumor cells and tumor microenvironment (TME). Iron is...
6.
Limone A, Maggisano V, Sarnataro D, Bulotta S
Cell Mol Life Sci
. 2023 Jul;
80(8):207.
PMID: 37452879
The cellular prion protein (PrP) is well-known for its involvement, under its pathogenic protease-resistant form (PrP), in a group of neurodegenerative diseases, known as prion diseases. PrP is expressed in...
7.
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells
Maggisano V, Capriglione F, Verrienti A, Celano M, Sponziello M, Pecce V, et al.
Endocrine
. 2022 Dec;
79(3):517-526.
PMID: 36474133
Purpose: In this study, we evaluated the biological role of miRNA-31-5p in papillary thyroid cancer (PTC). Methods: By using the real-time PCR, we measured miRNA-31-5p expression levels in 25 PTC...
8.
Celano M, Gagliardi A, Maggisano V, Ambrosio N, Bulotta S, Fresta M, et al.
Micromachines (Basel)
. 2022 Oct;
13(10).
PMID: 36295933
The manuscript describes the development of zein nanoparticles containing paclitaxel (PTX) and the bromo-and extra-terminal domain inhibitor (S)-tertbutyl2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate (JQ1) together with their cytotoxicity on triple-negative breast cancer cells. The rationale...
9.
Maggisano V, Capriglione F, Verrienti A, Celano M, Gagliardi A, Bulotta S, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625697
The release of molecules in exosomal cargoes is involved in tumor development and progression. We compared the profiles of exosomal microRNAs released by two thyroid cancer cell lines (TPC-1 and...
10.
Oliverio M, Bulotta S, Duarte N
Front Pharmacol
. 2022 Feb;
13:859549.
PMID: 35222054
No abstract available.